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Abstract Two new bismacrocyclic Gd
3+ chelates con-
taining a speciﬁc Ca
2+ binding site were synthesized as
potential MRI contrast agents for the detection of Ca
2+
concentration changes at the millimolar level in the
extracellular space. In the ligands, the Ca
2+-sensitive
BAPTA-bisamide central part is separated from the DO3A
macrocycles either by an ethylene (L
1) or by a propylene
(L
2) unit [H4BAPTA is 1,2-bis(o-aminophenoxy)ethane-
N,N,N0,N0-tetraacetic acid; H3DO3A is 1,4,7,10-tetraaza-
cyclododecane-1,4,7-triacetic acid]. The sensitivity of the
Gd
3+ complexes towards Ca
2+ and Mg
2+ was studied by
1H relaxometric titrations. A maximum relaxivity increase
of 15 and 10% was observed upon Ca
2+ binding to Gd2L
1
and Gd2L
2, respectively, with a distinct selectivity of
Gd2L
1 towards Ca
2+ compared with Mg
2+. For Ca
2+
binding, association constants of log K = 1.9 (Gd2L
1) and
log K = 2.7 (Gd2L
2) were determined by relaxometry.
Luminescence lifetime measurements and UV–vis spec-
trophotometry on the corresponding Eu
3+ analogues
proved that the complexes exist in the form of monohy-
drated and nonhydrated species; Ca
2+ binding in the
central part of the ligand induces the formation of the
monohydrated state. The increasing hydration number
accounts for the relaxivity increase observed on Ca
2+
addition. A
1H nuclear magnetic relaxation dispersion and
17O NMR study on Gd2L
1 in the absence and in the
presence of Ca
2+ was performed to assess the microscopic
parameters inﬂuencing relaxivity. On Ca
2+ binding, the
water exchange is slightly accelerated, which is likely
related to the increased steric demand of the central part
leading to a destabilization of the Ln–water binding
interaction.
Keywords Relaxivity   MRI contrast agents  
Calcium sensitive   Lanthanide complexes  
Luminescence
Introduction
Magnetic resonance imaging (MRI) is one of the most
versatile techniques in clinical and experimental in vivo
imaging. It provides excellent three-dimensional spatial
resolution down to the 10-lm range, whole body coverage
and the opportunity to noninvasively measure additional
physiological parameters [1]. Its sensitivity is, however,
2–6 orders of magnitude lower than that of optical
imaging. This can be overcome by using appropriate
MRI contrast agents. Nowadays, more than 30% of
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contrast agents [2]. By accelerating the longitudinal or
transverse relaxation of water protons, they increase the
signal-to-noise ratio, which, in turn, positively inﬂuences
the image contrast. The currently used clinical contrast
agents are mainly Gd
3+ chelates, making use of the high
magnetic moment (seven unpaired electrons) and slow
electronic relaxation of this paramagnetic lanthanide ion
[3, 4]. These contrast agents are, however, mostly non-
speciﬁc and provide only anatomical information.
Nowadays, there is an active search for new classes of
contrast agents capable of reﬂecting a change in biolog-
ical activity in their local environment. A new ﬁeld,
molecular imaging, is being developed, with the aim of in
vivo visualization of molecular events. Any molecular
imaging procedure requires an imaging probe that is
speciﬁc for a given molecular event. Examples of such
‘‘smart’’ potential contrast agents, sensing variables like
pH [5–7], partial oxygen pressure [8, 9], ion and metab-
olite concentration [10–14], or enzyme activity [15, 16]
have been described in the literature. They function on
the basis of the modulation of one or more microscopic
parameters of the Gd
3+ chelate determining relaxivity,
induced by a change in the local environment of the
agent. Among the variables that inﬂuence the relaxivity of
a contrast agent, the most important are the applied
magnetic ﬁeld (B0), the number of water molecules
directly bound to the paramagnetic center (q), their
exchange rate (kex), the water proton–Gd
3+ distance
(rGdH), the electron spin relaxation times (T1e, T2e), the
rotational correlation time (sR), and the presence and the
number of water molecules in the so-called second
coordination sphere (q
2nd)[ 2, 4, 17, 18].
Calcium (Ca
2+) is one of the most important metal ions
for life as it controls muscular contraction, neural cell
communication, hormonal secretion, etc. [19]. In the brain,
Ca
2+ acts as an important second messenger [20]. Synaptic
transmission depends on the entry of calcium ions at the
presynaptic terminal to cause fusion and release of vesi-
cles. Signiﬁcant changes in Ca
2+ concentration take place
during neuronal activity [21]. Tracking the dynamics of
Ca
2+ concentration changes could thus contribute to the
understanding of basic aspects of neuronal regulation or to
highlight the abnormalities in the diseased state [22].
Optical imaging based on ﬂuorescent dyes possessing a
calcium-dependent response has been widely used at the
cellular or cell population level [23]. However, the
intrinsic depth limitations associated with optical imaging
restrict these applications to superﬁcial regions. In contrast
to optical imaging, MRI has no depth penetration limits
and could be more adapted for tracking Ca
2+ changes. Li
et al. [11, 24] have proposed a potential MRI contrast
agent, GdDOPTA, whose relaxivity was reported to be
sensitive to Ca
2+ concentration in the 0.1–10-lM range.
The two macrocyclic subunits of the dimeric ligand
DOPTA serve as lanthanide(III) ion chelators, while the
BAPTA
4– subunit bridging the macrocycles is known
for its high selectivity towards Ca
2+ [H4BAPTA is 1,2-bis
(o-aminophenoxy)ethane-N,N,N0,N0-tetraacetic acid]. The
mechanism proposed for the Ca
2+-dependent relaxivity
change of GdDOPTA accounts for changes in the number
of water molecules directly bound to the paramagnetic
metal ion (q) upon Ca
2+ binding to the BAPTA
4– moiety.
BAPTA
4– was proposed a long time ago as a selective
ﬂuorescent indicator for Ca
2+ [25]. It presents several
advantages for biological Ca
2+ detection by optical
methods: integrated aromatic chromophore moiety and pH
insensitivity of Ca
2+ complexation thanks to the low val-
ues of the protonation constants (6.36 and 5.47, both
below physiological pH). More recently, another calcium-
sensitive MRI probe was proposed by Atanasijevic et al.
[20]. It is based on superparamagnetic iron oxide nano-
particles and calmodulin. In this approach, calcium-
dependent protein–protein interactions lead to particle
clustering and consequent changes in transverse relaxivity.
Similarly to GdDOPTA, this agent had calcium-response
in the micromolar Ca
2+ concentration range. It was
therefore proposed to detect elevated intracellular Ca
2+
levels, provided it is combined to a cellular delivery
system.
With the objective of detecting extracellular Ca
2+
concentration changes by MRI methods, we synthesized
two novel potential bismacrocyclic MRI contrast agents
(Structure 1). Two Gd
3+-loaded 1,4,7,10-tetraazacyclod-
odecane-1,4,7-triacetic acid (DO3A) derived units were
connected by a BAPTA-derived linker capable of Ca
2+
binding. However, in comparison with BAPTA
4–, the
Ca
2+ binding moiety in the central part of the ligand was
designed to have a reduced afﬁnity towards Ca
2+ in order
to shift to higher Ca
2+ concentrations the range where the
probe is expected to have a relaxivity response. The
conditional stability constant of GdDOPTA–Ca at physi-
ological pH was reported to be 1.0 · 10
6 M
–1 [11].
Similarly, the ﬂuorescent Ca
2+ indicators used in biolog-
ical applications and based on BAPTA
4– are adapted to
assess the cytosolic free Ca
2+ concentration in the
micromolar range. In contrast, the extracellular concen-
tration of Ca
2+ is in the millimolar range. The relaxivity
response of a probe with afﬁnity of K * 10
6 M for Ca
2+
would have already leveled off at the millimolar level.
The BAPTA
4– ligand was therefore modiﬁed by replacing
two carboxylates by the less strong donor amide func-
tions. As for the macrocyclic Gd
3+ binding site, it was
designed to respond to the presence of Ca
2+ by modula-
tion of the hydration number with consequent change in
the relaxivity.
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Structure 1
The proton relaxivities of the two new complexes were
studied by relaxometric titrations at different Ca
2+ con-
centrations and the relaxivity modulation by the Ca
2+
concentration changes was conﬁrmed. We speciﬁcally
aimed to identify the microscopic factors responsible for
the Ca
2+-dependent relaxivity response. To this end, a
detailed mechanistic study was carried out. We used UV–
vis absorption and luminescence lifetime measurements on
the corresponding Eu
3+ complexes to assess the number of
inner-sphere water molecules and their variation on Ca
2+
addition. The Gd2L
1 complex was characterized by vari-
able-temperature
17O NMR spectroscopy and variable-ﬁeld
relaxivity measurements (nuclear magnetic relaxation dis-
persion, NMRD). The experimental data were evaluated on
the basis of the Solomon–Bloembergen–Morgan theory,
extended with a second-sphere contribution.
Experimental
Materials and methods
All chemicals were purchased at the purest grade
commercially available and were used without further
puriﬁcation. Cyclen was purchased from Strem, France.
Bromoethylamine hydrogen bromide, bromopropylamine
hydrobromide, tert-butyl bromoacetate, N-methylpyrollid-
inone (dry), pyridine, H4BAPTA, acetic anhydride and
N,N-dimethylformamide (extra dry) were purchased from
Sigma-Aldrich, Germany. Toluene, acetonitrile, dichloro-
methane and methanol were purchased as analytical grade
solvents from Acros Organics, Germany. Lanthanide(III)
chlorides were prepared by dissolving metal(III) oxides
(Aldrich) in a slight excess of HCl (Carlo Erba, 37%)
followed by evaporation of solvents and dissolution in
H2O.
High-performance liquid chromatography (HPLC) was
performed at room temperature using a Varian (Australia)
PrepStar instrument equipped with a PrepStar 335 photo-
diode array detector at 254 nm. Reversed-phase analytical
HPLC was performed in a stainless steel ChromSep (length
250 cm, internal diameter 4.6 mm, outside diameter 3/8 in.
and particle size 8 lm) C18 column (Varian). The ligands
were puriﬁed using the following gradient:
Method A: 40% solvent A (methanol) and 60% solvent
B (water) to 100% solvent B in 5 min running isocrati-
cally at 100% solvent B for 10 min and then to 60%
solvent B in the next 2 min.
Method B: 95% solvent A (acetonitrile, 0.1% HCOOH)
and 5% solvent B (water, 0.1% HCOOH) to 70% solvent
B in 10 min and then 100% in the next 8 min running
isocratically for 12 min after that and then to 5% in next
2 min.
The ﬂow rate used for analytical HPLC was 1 mL min
–1
and for preparative 65 mL min
–1. All solvents used were
HPLC grade ﬁltered through a 0.45-lm nylon-66 Millipore
ﬁlter prior to use.
1H and
13C NMR spectra were recorded using a Bruker
400 MHz spectrometer (
1H—internal reference CDCl3 at
7.27 ppm or D2O at 4.75 ppm;
13C—internal reference
CDCl3 at 77.0 ppm or tetramethylsilane at 0 ppm). All the
experiments were performed at 298 K. Electrospray ioni-
zation (ESI) low-resolution mass spectrometry (LRMS)
spectra were obtained using an SL 1100 system (Agilent,
Germany) with ion-trap detection in positive and negative
ion mode. IR spectra were recorded with a Nicolet Impact
400 D spectrometer using neat compounds as disks with
KBr and only the major bands were noted. UV–vis spectra
of
5D0 /
7F0 transitions of Eu2L
1 were obtained with a
PerkinElmer Lambda 19 spectrometer in the region 577–
581 nm with data steps of 0.05 nm [26]. The concentra-
tions of the samples were approximately 0.02 M and the
temperature dependence was measured in the interval 288–
323 K in the absence and presence of Ca
2+. To maintain a
constant temperature, thermostatizable cells with a 10-cm
optical length were used. The luminescence measurements
were performed with a Varian Eclipse spectroﬂuorimeter,
equipped with a 450-W xenon arc lamp, a microsecond
ﬂash lamp and a red-sensitive photomultiplier (300–
850 nm). The luminescence spectra were obtained after
excitation of the
5L6 /
7F0 band (394 nm). An aqueous
solution (0.02 M) of Eu2L
1 was measured at 298 K in the
absence and presence of Ca
2+.
The
1H NMRD proﬁles were recorded at the Laboratory
of Inorganic and Bioinorganic Chemistry, Ecole Poly-
technique Fe ´de ´rale de Lausanne, Switzerland, using a
Stelar Spinmaster FFC fast-ﬁeld-cycling relaxometer cov-
ering magnetic ﬁelds from 2.35 · 10
–4 to 0.47 T (proton
Larmor frequency range 0.01–20 MHz). The temperature
was controlled by a VTC90 temperature control unit and
ﬁxed by a gas ﬂow. At higher ﬁelds, the relaxivity was
recorded using Bruker Minispecs mq30 (30 MHz), mq40
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(200 MHz) cryomagnet connected to a Bruker Avance 200
console and with a Bruker Avance 500 spectrometer
(500 MHz). The temperature was measured by a substitu-
tion technique [27] or via a preliminary calibration using
methanol and ethylene glycol standards [28]. The longi-
tudinal (1/T1) and transverse (1/T2)
17O NMR relaxation
rates were measured in the temperature range 277–344 K.
The data were recorded using a Bruker Avance 500
(11.75 T, 67.8 MHz) spectrometer. The temperature was
calculated according to a previous calibration with ethylene
glycol and methanol [28]. The samples were measured in
5-mm NMR tubes and were enriched with tert-butanol to
allow for the bulk magnetic susceptibility correction [29].
The 1/T1 data were obtained by the inversion recovery
method, while the 1/T2 data were measured by the Carr–
Purcell–Meiboom–Gill spin-echo technique. Acidiﬁed
water (HClO4, pH 3.8) was used as an external reference.
Analyses of the
17O NMR and
1H NMRD experimental
data were performed with the Visualiseur/Optimiseur pro-
grams running on a MATLAB platform version 6.5 [30,
31].
Synthesis
Compound 4a was synthesized according to a previously
reported procedure [32]. With use of an analogous method,
compound 4b was synthesized via 3b from the substrate 1b
[33].
Compound 3b.
1H NMR (CDCl3, 400 MHz), d (ppm):
6.97–6.84 (m, 5H), 4.65 (s, 2H), 2.98–2.89 (m, 2H), 2.86–
2.70 (m, 5H), 2.70–2.60 (m, 3H), 2.58–2.17 (m, 7H), 2.16–
1.75 (m, 9H), 1.32 (br s, 2H), 1.06–1.03 (m, 27H).
13C
NMR 172.2, 171.2, 155.2, 152.9, 135.6, 127.1, 126.4, 81.3,
81.0, 65.7, 64.7, 55.4, 50.3, 48.9, 38.5, 37.8, 28.2, 26.7,
26.5, 25.2. ESI–MS m/z:[ M+H ]
+ calcd for C37H63N5O8,
705.5; found, 706.5.
Compound 4b.
1H NMR (CDCl3, 400 MHz), d (ppm):
8.19 (br s, 2H), 3.42–2.99 (m, 8H), 2.85–2.20 (m, 16H),
1.61 (br s, 2H), 1.41 (s, 27H).
13C NMR (CDCl3,
100 MHz), d (ppm): 172.0, 169.8, 81.8, 81.1, 57.2, 55.9,
50.1, 49.4, 48.9, 38.5, 27.2, 27.1, 22.9. ESI–MS m/z:
[M + H]
+ calcd for C29H57N5O6, 571.4; found, 572.4 .
General method for the synthesis of compounds 6a and 6b
Compound 4a or 4b (2 mmol) was dissolved in 5 mL of
dry N-methylpyrollidinone with 50 lL of dry Et3N and
heated at 333 K for 15 min. Anhydride 5 [34] was then
added to this reaction mixture (295 mg, 0.67 mmol) in
small lots under N2. After complete addition of 5, the
solution was kept under continuous stirring at 333 K
overnight. It was then evaporated, dissolved in dichloro-
methane and extracted with water. The organic layer was
collected and evaporated to get a yellow oil. The crude
product was then puriﬁed by reversed-phase HPLC using
method A to get a light yellow ﬂuffy solid.
1,2-Bis{[2-{[({1-[1,4,7-tris(tert-butoxycarbonylmethyl)-
1,4,7,10-tetraazacyclododecane-10-yl]eth-2-yl}amino)car-
bonyl]methyl}-(carboxymethyl)amino]phenoxy}ethane, 6a.
Yield: 573 mg (55%)
1H NMR (CDCl3, 400 MHz), d
(ppm): 7.01–6.98 (m, 2H), 6.92–6.89 (m, 2H), 6.77–6.74
(m, 4H), 4.56 (d, J = 6.4 Hz, 2H, CHHO), 4.34 (d,
J = 15.5 Hz, 2H, CHHCONH), 4.01 (d, J = 17.8 Hz, 2H,
CHHCOOH), 3.91 (d, J = 6.4 Hz, 2H, CHHO), 3.48 (d,
J = 17.8 Hz, 2H, CHHCOOH), 3.36–3.21 (m, 22H), 3.08–
2.80 (m, 12H), 2.78–2.69 (m, 6H), 2.76–2.56 (m, 18H),
1.47 (s, 36H), 1.43 (s, 18H).
13C NMR (CDCl3, 100 MHz),
d (ppm): 175.2 (CONH), 175.0 (CONH), 170.2, 170.1,
149.4, 139.2, 120.6, 119.5, 115.4, 112.1, 81.8, 81.5, 66.4
(CH2O), 60.7 (NCH2CONH), 58.5 (CH2COOH), 56.5,
54.8, 53.5, 51.3, 50.3, 49.7, 47.8, 32.1 (CH2CH2CONH),
29.6, 28.1. ESI–MS m/z:[ M + H ]
+ calcd for C78H130
N12O20, 1,554.9; found, 1,555.9.
1,2-Bis{[3-{[({1-[1,4,7-tris(tert-butoxycarbonylmethyl)-1,
4,7,10-tetraazacyclododecane-10-yl]prop-3-yl}amino)car-
bonyl]methyl}-(carboxymethyl)amino]phenoxy}ethane, 6b.
Yield: 424 mg (40%).
1H NMR (CDCl3, 400 MHz), d
(ppm): 7.08–7.06 (m, 2H), 6.91–6.89 (m, 2H), 6.85–6.82
(m, 4H), 4.49 (br s, 2H), 4.31 (br s, 4H), 4.08–3.73 (m, 8H),
3.57–3.09 (m, 20H), 3.04–2.47 (m, 32H), 2.40 (br s, 4H),
2.01 (br s, 2H), 1.53 (s, 18H), 1.48 (s, 36H).
13CN M R
(CDCl3, 100 MHz), d (ppm): 175.7, 173.4, 170.9, 170.2,
150.2, 139.8, 120.3, 120.2, 115.7, 112.2, 82.2, 82.0, 66.6,
61.0, 58.7, 56.5, 55.3, 49.6, 49.1, 47.6, 35.5, 28.6, 28.4,
22.2. ESI–MS m/z:[ M+H ]
+ calcd for C80H134N12O20,
1,582.9; found, 1,584.0.
General method for the synthesis of L
1 and L
2
Neat triﬂuoroacetic acid (70 mL) was added to the previ-
ously obtained compound 6a or 6b (0.32 mmol) and the
reaction was kept at room temperature for 24 h. Triﬂuo-
roacetic acid was then evaporated, and the residue was
dried under vacuum and puriﬁed by reversed-phase HPLC
using method B.
1,2-Bis{[2-{[({1-[1,4,7-tris(carboxymethyl)-1,4,7,10-
tetraazacyclododecane-10-yl]eth-2-yl}amino)carbonyl]me-
thyl}-(carboxymethyl)amino]phenoxy}ethane, L
1. Yield:
220 mg (60%).
1H NMR (CDCl3, 400 MHz), d (ppm):
7.06–6.99 (m, 4H), 6.94 (t, J = 7.0 Hz, 2H), 6.87–6.85
(m, 2H), 4.27 (s, 4H), 3.83 (s, 4H), 3.77 (s, 4H), 3.58 (br s,
8H), 3.45 (s, 4H), 3.28–3.12 (m, 24H), 3.02–2.97 (m, 4H),
38 J Biol Inorg Chem (2008) 13:35–46
1232.82–2.75 (m, 12H).
13CN M R( D 2O, 100 MHz), d (ppm):
177.6, 174.7, 170.5, 169.9, 150.1, 138.9, 122.5, 121.4,
117.4, 113.0, 67.0, 57.9, 56.7, 56.1, 55.3, 51.0, 50.6, 50.5,
49.2, 47.6, 33.5. IR (cm
–1): 3,426 (vs), 2,964 (m), 2,929
(m), 2,860 (m), 1,718 (s), 1,637 (vs), 1,384 (s), 1,355 (s),
1,328 (m), 1,240 (s), 1,203 (s), 762 (m), 694 (m). ESI–MS
m/z: [M–H]
– calcd for C54H82N12O20, 1,218.57; found,
1,217.7.
1,2-Bis{[3-{[({1-[1,4,7-tris(carboxymethyl)-1,4,7,10-
tetraazacyclododecane-10-yl]prop-3-yl}amino)carbonyl]
methyl}-(carboxymethyl)amino]phenoxy}ethane, L
2.Y i e l d :
126 mg from 400 mg of 6b (40%). 1H NMR (D2O,
400 MHz), d (ppm): 6.98–6.91 (m, 4H), 6.88 (t, J = 7.4,
2H), 6.82–6.80 (m, 2H), 4.20 (s, 4H), 3.78 (s, 4H), 3.74 (s,
4H), 3.57 (s, 4H), 3.39–3.31 (m, 8H), 3.27–3.20 (m, 8H),
3.13–2.92 (m, 20H), 2.89–2.83 (m, 8H), 2.65 (br s, 4H),
1.61–1.53 (m, 4H).
13CN M R( D 2O, 100 MHz), d (ppm):
177.7, 174.4, 149.9, 138.5, 122.3, 121.5, 117.4, 113.2,
67.1, 57.6, 56.2, 56.1, 55.4, 50.9, 50.5, 49.6, 49.2, 36.4,
22.6. ESI–MS m/z: [M–H]
– calcd for C56H86N12O20,
1,246.6; found, 1,245.6.
Preparation of solutions of lanthanide(III) complexes
The complexes used for
1H and
17O relaxometric and UV–
vis measurements were prepared by mixing a slight excess
(5%) of the ligand solution with the appropriate lantha-
nide(III) chloride solution. The pH was adjusted to 7 using
KOH solution and the reaction mixture was stirred at
323 K overnight. The absence of free Ln
3+ was checked by
xylenol orange indicator in HCl/urotropine buffer (pH 5.8).
For each Gd2L sample, the Gd
3+ concentration was deter-
mined by measuring the bulk magnetic susceptibility shifts
[35].
Gd2L
1. ESI–LRMS m/z: [M–H + Na]
– calcd for
C78H124Gd2N12O20, 1,525.1; found, 1,547.6. IR: 3,448
(vs), 1,602 (vs), 1,560 (s), 1,400 (m), 1,323 (m), 1,242 (m),
1,203 (vs), 1,085 (m), 762 (m), 723(m).
Eu2L
1. ESI–LRMS m/z: [M–H]
– calcd for C54H76Eu2
N12O20, 1,156.4; found 1,155.5.
Gd2L
2. ESI–LRMS m/z:[ M+H ]
+ calcd for C56H80Gd2
N20O12, 1,553.1; found, 1,553.6.
Relaxometric Ca
2+ titrations of Gd2L
1 and Gd2L
2
The titrations were performed at 11.75 T, 298 K and pH 7.3
[maintained by N-(2-hydroxyethyl)piperazine-N0-ethane-
sulfonic acid buffer]. A solution of CaCl2 of known
concentration was added stepwise to the complex solution
and the longitudinalproton relaxationtime T1was measured
after each Ca
2+ addition. The initial Gd
3+ concentrations
were 7.4 and 4.0 mM for Gd2L
1 and Gd2L
2, respectively.
The relaxivity r1 was calculated from Eq. 1, using the actual
Gd
3+ concentration at each point of the titration:
1
T1;obs
¼
1
T1;d
þ r1 Gd ½  ; ð1Þ
where T1,obs is the observed longitudinal relaxation time,
T1,d is its diamagnetic contribution in the absence of the
paramagnetic substance and [Gd] is the concentration of
Gd
3+.
Relaxometric Mg
2+ titration of Gd2L
1
The titration was done analogously to the Ca
2+ titration
(B = 11.75 T, 298 K; initial Gd
3+ concentration of 2.6 mM).
When the Mg
2+-to-complex ratio was 23 (in the Ca
2+
titration, the plateau was already reached at this Ca
2+-
to-Gd2L
1 ratio), a Ca
2+ solution was added stepwise and
the relaxivity was measured.
Results and discussion
Synthesis of ligands
The ligands were prepared from the appropriate anhydride
and amine precursors in a facile two-step procedure as
shown in Scheme 1. Compounds 1a, 1b, 2 and 5 were
synthesized according to reported procedures [32–34].
Protected amines 3a an 3b were synthesized by alkylating
2 with 1a or 1b in acetonitrile. Hydrogenation of the
resulting products in methanol using 10% Pd on carbon as
a catalyst yielded 4a and 4b. Bismacrocycles 6a and 6b
were obtained by coupling of amines 4a or 4b to an
anhydride 5 in N-methylpyrrolidinone and triethylamine.
After the puriﬁcation, they were hydrolyzed with neat tri-
ﬂuoroacetic acid and puriﬁed by reversed-phase HPLC
giving the ﬁnal ligands L
1 and L
2. It is interesting to note
that an additional proof for the extremely high steric con-
straints in the bismacrocyclic systems studied was observed
in 2D NMR (correlation spectroscopy, heteronuclear single
quantum coherence) spectra of 6a (Figs. S13, S14). The
splitting of the signals occurs on all methylene groups not
belonging to the macrocyclic ring; this disappears upon the
removal of tert-butyl protective groups in L
1.
Relaxometric Ca
2+ titrations of Gd2L
1 and Gd2L
2
The titration curves are represented as the variation of the
relaxivity of the Gd
3+ complex solution versus the Ca
2+
concentration (Fig. 1). The maximum relaxivity increase
J Biol Inorg Chem (2008) 13:35–46 39
123upon Ca
2+ addition was 15% for Gd2L
1 and 10% for
Gd2L
2. The saturation of both curves occurs at relatively
high Ca
2+ concentrations (approximately 20 equiv of Ca
2+
for Gd2L
1 and approximately 5 equiv of Ca
2+ for Gd2L
2).
The titration curves were ﬁtted to obtain the apparent
association constants, which are log K = 1.9 ± 0.2 and
log K = 2.7 ± 0.2 for Gd2L
1 and Gd2L
2, respectively.
Similarly to the case for previously investigated BAPTA-
type complexes [11, 25], 1:1 binding stoichiometry has
been assumed. These association constants are to be
compared with the conditional stability constant, log
Kcond = 6.9 of CaBAPTA
2– at pH 7.0, calculated by taking
into account the protonation constants of BAPTA
4– [25].
The constants obtained for our systems are 3–4 orders of
magnitude lower. This difference can be rationalized by the
fact that even on Ca
2+ binding, the amide groups of the
ligand remain coordinated to the lanthanide as indicated by
proton relaxivity and luminescence data on the Gd
3+ and
Eu
3+ complexes, respectively (see below). Therefore, in
comparison with CaBAPTA
2–, there are two carboxylate
donors fewer coordinating to the Ca
2+ ion, which is
responsible for the considerably reduced stability. It is
interesting to note that the stability of the Gd2L
2–Ca
complex is somewhat higher than that of Gd2L
1–Ca. This is
likely related to the higher ﬂexibility of the Ca
2+ binding
site in Gd2L
2–Ca, where the propylene linker between the
macrocycle and the Ca
2+ binding site induces fewer steric
constraints, hence ensuring a better ‘‘overwrapping’’ of the
cation by the chelator. We have to note that for GdDOP-
TA-Ca, possessing an integral BAPTA
4– unit for Ca
2+
binding, Li et al. [11] reported a much higher apparent
association constant, K = 1.0 · 10
6 M.
Relaxometric Mg
2+ titration of Gd2L
1
The relaxivity remains approximately constant upon addi-
tion of Mg
2+, then it increases upon Ca
2+ addition even in
the presence of a large amount of Mg
2+ (Fig. 2). The re-
laxivity increase after Ca
2+ addition (16%) was similar to
that observed in the Ca
2+ titration without the presence of
Mg
2+. The insensitivity of Gd2L
1 towards Mg
2+ is due to
the lower stability of BAPTA-derived complexes with
Mg
2+ compared with Ca
2+. The titration curve shows that,
though the afﬁnity of our chelator for Ca
2+ is diminished in
comparison with BAPTA
4–, the selectivity versus Mg
2+ is
conserved. The discrimination of BAPTA-type ligands
towards Ca
2+ compared with Mg
2+ is supposed to stem
from the right size of the binding cavity for the larger-sized
Ca
2+, which is already too big for Mg
2+ and cannot
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123constrict further to envelop snugly this smaller cation (the
association constant of MgBAPTA
2– is log K = 1.8) [25].
Spectrophotometric measurements on the Mg
2+–BAPTA
system proved that Mg
2+ coordination affects only half of
the ligand, in contrast to Ca
2+ coordination, where the
entire ligand is involved [25].
Luminescence and UV–vis absorption studies to assess
the hydration state of Eu2L
1
In order to determine the number of water molecules
coordinated to the lanthanide ion before and after Ca
2+
binding to the complex, we performed luminescence life-
time measurements on Eu2L
1 in H2O and D2O solutions
[36–38]. In the absence of Ca
2+, the luminescence lifetimes
are sH2O ¼ 0:328ms and sD2O ¼ 0:408ms. The hydration
number, q = 0.4, was calculated according to the revised
equation of Beeby et al. [38] which involves a correction
for the contribution of second-sphere water molecules
(Eq. 2):
q ¼ A0ðDkH2O   kD2OÞcorr; ð2Þ
where A0 is 1.2 ms and the correction factor for the con-
tribution of the second sphere is –0.25 m s
–1. The
longitudinal
17O and
1H relaxation rates (vide supra)
indicate that we cannot neglect the effect of second-sphere
water molecules. The noninteger hydration number sug-
gests the presence of both q = 1 and q = 0 species. Upon
the addition of Ca
2+ to the Eu
3+ complex, the hydration
number determined by luminescence increases to q & 0.7
ðsH2O ¼ 0:422ms and sD2O ¼ 0:661msÞ (Fig. 3). Such an
increase of q can be interpreted in terms of a shift towards
the monohydrated species.
To investigate further the hydration state, variable-tem-
perature UV–vis measurements were performed on Eu2L
1.
In general, the presence of a hydration equilibrium of
europium(III) species leads to the appearance of two
absorption bands for the
5D0 /
7F0 transition with peak
separations of more than 0.5 nm [39, 40]. High-resolution
UV–vis absorption spectra of a Eu2L
1 aqueous solution (pH
7) were recorded in the 577–581-nm region at various
temperatures and Ca
2+ concentrations. The measurements
revealed two temperature-invariant absorption bands,
which could be deconvoluted into two symmetrical peaks
(Fig. 4). The separation of those peaks is about 0.5 nm and
lies in the range typical of different coordination environ-
ments of Eu
3+ [41, 42]. We assume that in the absence of
Ca
2+, there are two nine-coordinate species present; in both
species the amines and carboxylates of the macrocycle as
well as the amide oxygen are coordinated to the lanthanide,
and either carboxylate from the central part or one water
molecule completes the coordination sphere to a coordina-
tion number of nine,which is the usual coordination number
for this type of Ln
3+ complex (Fig. 5). The coordination of
amide oxygens is supported by IR measurements performed
on the ligand L
1 and its Gd
3+ complex: the comparison of
the two IR spectra (Figs. S5, S6) shows that the amide
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123absorption is affected by complexation to the lanthanide
ion.
Among analogous structures, lanthanide complexes of
monomeric DO3A derivatives bearing –(CH2)n–NHCO–R
(n = 2, 3) amide units have been reported in the literature
[43]. With Eu
3+ and Gd
3+, the n = 2 ligand forms mono-
hydrated complexes, while the n = 3 ligand forms
nonhydrated complexes. In contrast to this, Eu2L
1 contains
a carboxylate in the central part as a potential donor which
can partially replace the water molecule in the inner
coordination sphere. This leads to the presence of the two
structures as proposed in Fig. 5, and consequently to a
reduced hydration number.
Upon Ca
2+ addition to a Eu2L
1 solution, the relative
intensity of the two UV–vis absorption bands changes: the
band at higher wavelengths decreases, while the other band
increases (Fig. 4)[ 44]. In parallel, the luminescence mea-
surements indicate an increase of the hydration number.
Therefore, we conclude that the band which decreases in
intensity (at 579.9 nm) on Ca
2+ addition can be attributed
to the q = 0 complex, while the band which increases in
intensity (579.3 nm) can be attributed to the monohydrated
complex. We assume that both in the presence and in the
absence of Ca
2+, the amide oxygen remains coordinated to
the lanthanide ion to preserve the overall coordination
number of nine. If the amide oxygen participated also in
the Ca
2+ coordination, the concomitant increase in the
hydration number and in relaxivity would be more prom-
inent than what is experimentally observed. The Ca
2+
binding in the central part of the complex demands the
coordination of the central carboxylates, which, by leaving
the coordination environment of Ln
3+, allow a water mol-
ecule to bind to the lanthanide ion. Therefore, the Ca
2+
binding in the central part will favor the formation of the
monohydrated complex (Fig. 5).
Relation between the Ca
2+-dependent hydration
number q and relaxivity
Upon stepwise addition of Ca
2+, we observe a good corre-
lation between the relaxivity increase of the Gd2L
1 complex
and the increase in q determined from the luminescence
lifetime measurements on the Eu
3+ analogue (Fig. 3). In
addition, we also calculated the ratio of the integrals of the
twoUV–visabsorptionbands(attributedtoq = 0andq =1 )
of Eu2L
1 at various Ca
2+ concentrations. The q values
obtained in this way overlap with those measured by lumi-
nescence. This supports our hypothesis that the complex
Ln2L
1 exists in the form of two differently hydrated species,
each with an overall coordination number of nine. As was
proved by the UV–vis studies, their ratio is temperature-
independent but it shifts towards the monohydrated species
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123with increasing Ca
2+ concentration, resulting in a relaxivity
increase.
The relaxivity of the Gd2L
2 complex is lower than that
of the L
1 analogue, which suggests that q is also lower. In
the case of the monomeric DO3A derivatives bearing –
(CH2)n–NHCO–R amide units, with the propyl-linked
(n = 3) amide q = 0 was determined for the Eu
3+ and Gd
3+
complexes [43]. The extra steric demand associated with
the enlargement of the chelate ring incorporating the amide
carbonyl group was found to be sufﬁcient to suppress water
coordination. For Gd2L
2, the relaxivities suggest q[0.
Moreover, the relaxivity increases on Ca
2+ addition, though
to a smaller extent than for Gd2L
1. Therefore, we assume
that two differently hydrated species exist also for Ln2L
2
complexes, with an increased proportion of the nonhy-
drated species compared with Ln2L
1. The relaxivity change
observed on Ca
2+ addition indicates that the central car-
boxylate participates in the lanthanide coordination; on
Ca
2+ binding this carboxylate is removed from the lan-
thanide ion and replaced by a water molecule. The small
relaxivity change shows that the participation of this car-
boxylate in the lanthanide coordination is limited with
respect to Gd2L
1.
For GdDOPTA, Li et al. [11, 24] reported a more
important variation of q and a correspondingly greater re-
laxivity change on Ca
2+ binding. This is likely related to
the more ﬂexible nature of the central BAPTA
4– part of the
DOPTA ligand in contrast to the BAPTA-bisamide moiety
in our case, where the monoamide functionalities are
integrated in the central skeleton of the ligand and have
much less ﬂexibility to change coordination from Gd
3+ to
Ca
2+.
1H and
17O relaxation studies of Gd2L
1: evaluation
of the parameters inﬂuencing proton relaxivity
1H NMRD proﬁles were recorded for Gd2L
1 with and
without Ca
2+. In the presence of Ca
2+, an increase in the
relaxivity was observed at all frequencies, related to an
increase in the hydration number. The relaxivity at 20 MHz
and 298 K in the absence and presence of Ca
2+ is 5.74 and
6.13 mM
–1 s
–1, respectively, slightly higher than the re-
laxivites of currently used MRI contrast agents [2, 4, 19,
45].
The transverse
17O relaxation rates indicate a relatively
slow water exchange (Fig. 6), which is visible from the
curve of ln(1/T2r) versus inverse temperature: at low tem-
peratures, 1/T2r decreases with decreasing temperature. The
reduced chemical shifts (Dxr) in the absence of Ca
2+ are
smaller than would be expected for a q = 0.4 complex.
Such small chemical shifts have previously been observed
in systems with a signiﬁcant second-sphere contribution
[46]. Therefore, the chemical shifts were not included in
the ﬁnal ﬁtting. For the Ca
2+-free system, the transverse
and longitudinal
17O relaxation rates and the
1H NMRD
data were analyzed simultaneously (Fig. 6) on the basis of
the Solomon–Bloembergen–Morgan approach, extended
by a second-sphere contribution [46, 47]. The presence of
free carboxylates in the complex induces a second-sphere
contribution that affects both
1H and
17O longitudinal
relaxation. In fact, by ﬁtting the
17O1 / T1 values without
second-sphere contribution, we obtained inconceivably
high rotational correlation times. The inner-sphere hydra-
tion number q was ﬁxed to 0.4, the value found by
luminescence measurements on Eu2L
1. Since Eu
3+ and
Gd
3+ have similar ionic radii, we expect a similar hydration
mode for Gd2L
1. To describe the second-sphere contribu-
tion, one water molecule per Gd
3+ (q
2nd = 1) was
considered during the ﬁtting. The distance between the
Gd
3+ ion and the second-sphere water proton and oxygen
was ﬁxed to rGd–H
2nd = 3.5 A ˚ and rGd–O
2nd = 4.1 A ˚, respec-
tively, the enthalpy of activation to DH
#2nd = 35 kJ mol
–1,
and the second-sphere water residence time to sm
2nd =5 0p s
[46, 47]. Other parameters were also ﬁxed during the ﬁtting
in order to add some constraints. They are as follows: the
hyperﬁne coupling constant, A/ h = –3.8 MHz; the distance
between Gd
3+ and the oxygen and the proton of the ﬁrst-
sphere water molecule, rGdO = 2.5 A ˚ and rGdH = 3.1 A ˚,
respectively. The distance of the closest approach of outer-
sphere water molecules to Gd
3+, a, was ﬁxed to 3.6 A ˚. The
quadrupolar coupling constant [v(1 + g
2/3)
1/2] was set to
7.58 MHz, the value of pure water. The activation energy
Ev had to be ﬁxed to 1 kJ mol
–1, otherwise the ﬁt con-
verged to negative values. In the ﬁtting procedure, we used
a model which considers different rotational correlation
times for Gd–O and Gd–H rotating vectors (sRO
298 and sRH
298,
respectively) [48]. For geometrical reasons, their ratio
(sRH
298/sRO
298) has to lie between 0.65 and 1. The most
important parameters obtained from the best simultaneous
least-squares ﬁt to the experimental data are listed in
Table 1. For the complete ﬁtting results, see Table S9.
The water exchange of Gd2L
1 is slightly slower than that
found for gadolinium 1,4,7,10-tetraazacyclododecane-
1,4,7,10-tetraacetate (GdDOTA) [49]. It is interesting to
note that for the monohydrated Gd
3+ complex of the DO3A
ligand bearing an N-linked CH2CH2NHCO-pyridyl pen-
dant arm, much faster water exchange has been reported
(kex
298 = 1.1 · 10
8 s
–1)[ 43]. This fast water exchange has
been explained by the steric destabilization of the Ln–water
binding interaction by the presence of the bulky sub-
stituent. Such a destabilization effect is expected to be less
important in Gd2L
1 since the amide carbonyl is linked to a
ﬂexible –CH2–N– moiety in contrast to the direct attach-
ment to a pyridyl group in the previous case. This limited
steric constraint around the water binding site will then be
J Biol Inorg Chem (2008) 13:35–46 43
123translated by a more sluggish water exchange as observed
for Gd2L
1. The more than 1 order of magnitude difference
in the water exchange rate between Gd2L
1 and the Gd
3+
complex of the DO3A–CH2CH2NHCO–pyridyl ligand is a
good example of the importance of the steric compression
around the water binding site. Steric compression is indeed
the main factor determining the rate of exchange in a
dissociative water exchange mechanism, characteristic of
nine-coordinate complexes [50]. The dissociative activa-
tion mode for Gd2L
1 is indicated by the positive value of
the activation entropy.
The higher sr value of Gd2L
1 compared with that of
GdDOTA is rationalized by the higher molecular weight
and greater rigidity of the molecule. In spite of the slow
rotational motion and the presence of a second hydration
sphere in the bismacrocyclic system, the relaxivities are
only slightly higher than those of GdDOTA, owing to the
low hydration number of Gd2L
1 (q = 0.4).
The simultaneous ﬁt of the
1H and
17O relaxation rates
also supplies parameters that describe the electron spin
relaxation of the Gd
3+ complexes, such as sv, the correla-
tion time for the modulation of the zero ﬁeld splitting, its
activation energy, Ev, and the mean zero ﬁeld splitting
energy, D
2. The values obtained for Gd2L
1 are in the usual
range for similar complexes [49].
The
1H NMRD and
17O NMR data of the Gd2L
1 system
containing Ca
2+ could not be ﬁtted simultaneously because
the conditions for
17O NMR and
1H NMRD samples dif-
fered signiﬁcantly in terms of the ionic strength and
viscosity, and also in the Ca
2+-to-Gd
3+ ratio of the samples.
Only the
17O ln(1/T1r) and ln(1/T2r) data were analyzed,
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Table 1 Kinetic and structural parameters obtained from the ﬁt of
17O NMR and NMR dispersion (NMRD) data for the Gd2L
1 complex
in the absence and in the presence of Ca
2+, compared with those of
gadolinium 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
(GdDOTA)
Parameters Gd2L
1
17O NMR +
NMRD
Gd2L
1 +C a
2+
17O NMR
GdDOTA
17O NMR +
NMRD
a
kex
298 (10
6 s
–1) 2.4 ± 0.2 7.5 ± 1.6 4.1
DH
  (kJ mol
–1) 43.6 ± 3.3 43.6 49.8
DS
  (J mol
–1 K
–1) +23.5 +33.0 –
sRO
298 (ps) 350 ± 50 1,150 ± 250 77
Er (kJ mol
–1) 24 ± 1 21 ± 6 16.1
sv
298 (ps) 20.6 ± 2.7 0.13 ± 0.02 11
D
2 (10
20 s
–2) 0.46 ± 0.10 0.50 ± 0.05 0.16
q 0.4 0.7 1
q
2n s 11 –
r1
298 (mM
–1 s
–1)
20 MHz
5.74 6.13 4.74
Parameters in italics were ﬁxed during the ﬁtting
a Reference [49]
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1, in the presence
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2+. The curves correspond to the ﬁt as explained in the text
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123and the relaxivities are given in the electronic supple-
mentary material. The
17O relaxation rates were interpreted
by using the same set of equations as for the system
without Ca
2+ (Fig. 7). Analogously, the same parameters
were ﬁxed in the ﬁt (except for the hydration number,
q = 0.7, obtained from luminescence studies). The best
ﬁtting was obtained with the parameters listed in Tables 1
and S10. On Ca
2+ addition, the most ﬂagrant change is
observed for the rotational correlation time as obtained
from the
17O longitudinal relaxation rates (sR = 350 com-
pared with 1,150 ps without and with Ca
2+, respectively).
We attribute this signiﬁcant increase mainly to the high
ionic strength and viscosity of the
17O NMR sample con-
taining 1 M CaCl2, though some rigidiﬁcation of the
molecule on Ca
2+ is also expected. The water exchange
rate triples on Ca
2+ binding (kex
298 = 2.4 · 10
6 compared
with 7.5 · 10
6 s
–1). The decreasing negative charge of the
Ca
2+-bound Gd2L
1–Ca complex would be rather expected
to diminish the exchange rate in a dissociatively activated
process. Among other factors that can compensate this
effect, the increased steric demand of the central part after
Ca
2+ binding can lead to a steric destabilization of the Ln–
water binding interaction. Overall, the relaxivity increase
upon Ca
2+ addition is mainly related to an increase in the
hydration number.
Conclusion
With the objective of Ca
2+ sensing by MRI in the extra-
cellular space, we synthesized two novel bismacrocyclic
ligands containing a Ca
2+-sensitive BAPTA-bisamide
moiety (Scheme 1). Their Gd
3+ complexes exhibit relax-
ivities comparable to that of currently used monomeric
MRI contrast agents, in accordance with their larger size
but lower hydration numbers (q\1). Upon Ca
2+ addition,
the relaxivities of Gd2L
1 and Gd2L
2 increase by 15 and
10%, respectively. These changes are likely insufﬁcient for
in vivo MRI detection. Gd2L
1 is practically insensitive
towards Mg
2+. The apparent association constants for the
Ca
2+ interaction were obtained from the relaxometric
titration curves. They are several orders of magnitude
lower for our complexes than those determined for BAP-
TA
4– itself or other tetracarboxylate BAPTA
4– analogues.
The hydration number of Eu2L
1 was determined from
luminescence lifetime measurements in the absence
(q = 0.4) and presence (q = 0.7) of Ca
2+. UV–vis mea-
surements conﬁrmed the presence of two coordination
environments that we attribute to a monohydrated and a
nonhydrated state (Fig. 5). Upon the coordination of Ca
2+
in the central part of the ligand, the molecule undergoes a
conformational change and an acetate arm, originally
coordinated to the Ln
3+ ion, binds to Ca
2+ and leaves space
for the coordination of a water molecule to the lanthanide,
which shifts the hydration state towards the more hydrated
species.
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